INLYSE Malware.AI vs Nucleon Malprob: Side-by-Side Comparison (2026)
Features, pricing, ratings, and pros and cons, compared head to head.
INLYSE Malware.AI is a commercial malware analysis tool by INLYSE. Nucleon Malprob is a commercial malware analysis tool by Nucleon Security. Compare features, ratings, integrations, and community reviews side by side to find the best malware analysis fit for your security stack. Independent and vendor-neutral: our scores and rankings are earned, never bought — sponsored placement is always labeled.
CST VerdictShort answer
Startups and SMBs tired of signature-based detection gaps will find real value in Malware.AI's visual neural network approach to zero-day and APT identification without constant update cycles. The tool covers NIST DE.CM continuous monitoring across email, browser, and API channels, giving lean security teams detection capabilities that usually require enterprise budgets. Skip this if you need incident response automation or post-breach forensics; Malware.AI is detection-first and doesn't compensate for gaps downstream. Startups and SMBs with thin security staff should pick Nucleon Malprob for its API-first design, which lets you embed malware detection into existing workflows without hiring dedicated analysts. The tool detects zero-day attacks across six file formats and runs entirely cloud-based, so there's no infrastructure overhead. Skip this if you need post-incident forensics or threat hunting depth; Nucleon prioritizes detection over investigation, covering only the Detect and Identify phases of NIST CSF 2.0.
Based on our analysis of core features, integrations, company size fit, deployment model, here is our conclusion:
